CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
| Current price | $2.26 | 52-week high | $26.35 |
| Prev. close | $2.54 | 52-week low | $2.18 |
| Day low | $2.18 | Volume | 2,485,300 |
| Day high | $2.62 | Avg. volume | 1,111,950 |
| 50-day MA | $4.12 | Dividend yield | N/A |
| 200-day MA | $10.30 | Market Cap | 110.46M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
| 1-mo | -47.32% |
| 3-mo | -62.71% |
| 6-mo | -79.30% |
| 1-year | -87.74% |
| 3-year | -79.38% |
| 5-year | -82.94% |
| YTD | -90.04% |
| 2023 | 145.41% |
| 2022 | 144.06% |
| 2021 | -69.63% |
| 2020 | -10.67% |
| 2019 | N/A |
Loading social stream, please wait...